SEC Form 4 · accession 0001127602-19-008352
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Ross Smith
Officer — Corporate Executive VP & CFO
Period of report
Feb 25, 2019
Accepted (ET)
Feb 26, 2019 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2019 | S | 200 | $144.99 | D | 24,262 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.00 | D | 24,062 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.04 | D | 23,962 | D | |
| Common Stock | Feb 25, 2019 | S | 300 | $145.05 | D | 23,662 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.12 | D | 23,462 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.14 | D | 23,262 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.17 | D | 23,162 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.22 | D | 23,062 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.26 | D | 22,862 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $145.29 | D | 22,462 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.36 | D | 22,362 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.38 | D | 22,262 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.39 | D | 22,162 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.46 | D | 21,962 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.52 | D | 21,762 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.53 | D | 21,562 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.61 | D | 21,462 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.82 | D | 21,362 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.83 | D | 21,262 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.93 | D | 21,062 | D | |
| Common Stock | Feb 25, 2019 | S | 300 | $146.00 | D | 20,762 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $146.01 | D | 20,562 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $146.05 | D | 20,462 | D | |
| Common Stock | Feb 26, 2019 | F | 379 | $145.31 | D | 20,083 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.